Q2 Earnings Fail to Impress Pharma ETF By: TalkMarkets August 07, 2017 at 17:47 PM EDT Total earnings for 83.3% of the total healthcare market capitalization are up 6% on revenue growth of 4.1%. Read More >> Related Stocks: Bristol-Myers Squibb Eli Lilly Johnson & Johnson Merck & Co Pfizer S&P Pharmaceuticals SPDR US Pharmaceuticals Ishares ETF Vaneck Pharmaceutical ETF